Skip to main content
PhytoHealth logo

PhytoHealth — Investor Relations & Filings

Ticker · 4108 ISIN · TW0004108006 TW Manufacturing
Open in API
Filings indexed 1,638 across all filing types
Latest filing 2026-05-21 Annual Report
Country TW Taiwan
Listing TW 4108

About PhytoHealth

www.phytohealth.com.tw

PhytoHealth Corporation is a research-driven pharmaceutical company specializing in the development and commercialization of botanical new drugs. Utilizing a disease-targeted research model, the company translates historical clinical experiences with botanical medicine into modern therapeutic solutions. Its core portfolio includes PhytoHealth PG2®, an injectable treatment for cancer-related fatigue, and Naldebain®, an analgesic for moderate to severe acute pain. Beyond pharmaceutical development, the company leverages its expertise in astragalus extraction to produce specialized health supplements. PhytoHealth operates advanced manufacturing facilities compliant with PIC/S GMP standards, ensuring the quality and consistency of its phytomedicines. The company focuses on addressing unmet medical needs in oncology and pain management through innovative botanical science and rigorous clinical validation.

Recent filings

Filing Released Lang Actions
114年年報及股東會資料 — 2025_4108_20260609FE4.pdf
Annual Report Classification · 95% confidence The provided document is the detailed 2025 Annual Report for PhytoHealth Corporation, containing full financial statements, governance disclosures, operational overview, and management’s letter to shareholders. It is the complete annual report, not an announcement or summary. Therefore, it matches the Annual Report definition (code 10-K). FY 2025
2026-05-21 English
114年年報及股東會資料 — 2025_4108_20260609F04.pdf
Annual Report Classification · 98% confidence The provided document is titled “114年度年報” and contains the full annual report contents: a letter to shareholders, corporate governance report, fundraising and capital structure details, business overview, financial performance tables with actual financial data, R&D details, management review and complete supporting schedules. This is the complete Annual Report for the year (not merely an announcement of its publication) and matches the definition of a 10-K. FY 2025
2026-05-21 Chinese
114年年報及股東會資料 — 2026_4108_20260609F17.pdf
Regulatory Filings Classification · 65% confidence The provided document is a standalone “前十大股東相互關係表” (Top 10 shareholders interrelationship table) for the annual report period, rather than the full annual report itself. It contains no financial statements or earnings details, nor is it a formal proxy statement or management presentation; it is a regulatory schedule/form required by local listing rules. It does not announce dividends, financing, board changes, or other specific events, so it does not match any other precise filing category. Therefore, the most appropriate classification is the general “Regulatory Filings” fallback.
2026-05-21 Chinese
114年年報及股東會資料 — 2026_4108_20260609F13.pdf
AGM Information Classification · 93% confidence The document is clearly a shareholder meeting handbook (“股東常會議事手冊”) for the company’s 115th Annual General Meeting. It contains the AGM agenda, procedures, and detailed attachments (annual business report, audit committee report, financial statements, director candidate lists, governance documents, etc.) distributed to shareholders at or before the meeting. It is not a standalone annual/quarterly report, proxy card, or mere announcement but the full AGM materials. This corresponds to 'AGM Information' (Code: AGM-R).
2026-05-21 Chinese
114年年報及股東會資料 — 2026_4108_20260609FE2.pdf
AGM Information Classification · 85% confidence The document is titled “Handbook for the 2026 Annual Meeting of Shareholders” and contains the full agenda, meeting procedures, report items, election matters, and a series of attachments (business report, audit committee review, audited financial statements, director candidate bios, etc.). These are the materials prepared for and distributed at the company’s Annual General Meeting. It is not merely an announcement or proxy solicitation notice, nor is it the standalone annual report or financial statements—it is the compendium of presentations and materials for the AGM itself. Therefore, it best fits the AGM Information category (AGM-R).
2026-05-21 English
114年年報及股東會資料 — 2026_4108_20260609FE1.pdf
AGM Information Classification · 88% confidence The document is a detailed notice of the 2026 Annual General Shareholders’ Meeting, including meeting date, location, agenda items, election matters, proxy procedures, and voting instructions. This aligns with the definition of AGM Information (materials related to an Annual General Meeting). There is no actual financial data being reported (as in an annual report), no vote result declaration, nor other regulatory announcements.
2026-05-21 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.